Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt
World Journal of Hepatology · 27.08.2026 · 18 (8)
DOI: 10.4254/wjh.118661 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.08.2026. Verfasst von Nahed A Makhlouf. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Mogahed et al recently published a retrospective study in the World Journal of Hepatology , which assessed the safety and efficacy of the generic sofosbuvir (SOF)/ledipasvir (LED) in Egyptian hepatitis C virus (HCV)-infected children in comparison with the brand form. They concluded that, the use of generic SOF/LED in HCV infected children is safe and effective. Previous study in 2021 on chronic HCV in adolescents used the generic SOF/LED at Assiut, Upper Egypt. Sustained virologic response (SVR12) was 100% both in treatment naïve with or without haematological disorders and in non-responder to pegylated interferon/ribavirin. The treatment was well tolerated, with minimal side effects. We also support the use of the generic forms of SOF/LED in HCV infected children and adolescents in Egypt and other resource limited countries.
Zitieren
APA
Makhlouf, N. A. (2026). Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt. World Journal of Hepatology, 18(8). https://doi.org/10.4254/wjh.118661
Vancouver
Makhlouf NA. Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt. World Journal of Hepatology. 2026;18(8). doi:10.4254/wjh.118661
BibTeX
@article{Makhlouf2026,
author = {Makhlouf, Nahed A},
title = {Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt},
journal = {World Journal of Hepatology},
year = {2026},
volume = {18},
number = {8},
doi = {10.4254/wjh.118661}
}
EUVIMED